Integrating Acupuncture Into the Management of Migraines
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Integrating Acupuncture Into the Management of Migraines: A Randomized, Comparative Trial|
- Number and intensity of migraine headaches [ Time Frame: 16 weeks ] [ Designated as safety issue: No ]Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention
- Medication consumed [ Time Frame: 16 weeks ] [ Designated as safety issue: No ]Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention
|Study Start Date:||July 2011|
|Study Completion Date:||April 2013|
|Primary Completion Date:||April 2013 (Final data collection date for primary outcome measure)|
Active Comparator: Acupuncture group
Participants will keep a headache diary for 4weeks and then attend eight weekly acupuncture sessions. Acupuncture will be done by a licensed acupuncturist and will last approximately 25 minutes. Following the acupuncture sessions, participants will keep a headache diary for an additional 4 weeks
participants will receive 8 weekly acupuncture sessions. Acupuncture will be performed by a licensed acupuncturist. Each session will last approximately 25 minutes.
No Intervention: Control group
participants will be asked to maintain a daily diary of headache occurrences and OTC medication use for 16 weeks.
70 men and women between the ages of 18-65 diagnosed with migraines by a medical doctor. Participants must be using only nonprescription medication to treat their head pain.
Once initial eligibility has been determined and informed consent obtained, a Traditional Chinese Medicine (TCM) differential diagnosis will be carried out to determine the underlying cause of the migraines experienced by the participant. If the migraines are due to Liver Qi stagnation with Liver Yang rising they will be eligible for participation in the study. Eligible participants will be randomly assigned to one of two groups: Group 1 will continue taking their current nonprescription migraine medication as needed and will receive acupuncture once a week for 8 weeks. Group 2 will continue with their current nonprescription migraine medication as needed but will not receive acupuncture. The same set of predetermined acupuncture points will be used at each session.
All participants will complete a daily headache and medication use diary for four weeks on two separate occasions. In addition all participants will complete the Headache Impact Test (HIT-6) survey on three separate occasions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01481103
|United States, Illinois|
|Serenity Acupuncture and Oriental Medicine|
|Oak Park, Illinois, United States, 60302|
|Principal Investigator:||Patricia Miller, LAc, PT||National University of Health Sciences|
|Study Director:||Hui Yan Cai, LAc, PhD||National University of Health Sciences|